InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

Core Viewpoint - InspireMD, Inc. is set to release its fourth quarter and full year 2024 financial results on March 12, 2025, and will host a conference call to discuss these results and recent highlights [1]. Company Information - InspireMD, Inc. develops the CGuard™ Prime carotid stent system aimed at treating carotid artery disease (CAD) and preventing strokes [1]. - The company utilizes its proprietary MicroNet® technology to establish its products as the industry standard for carotid stenting, focusing on achieving excellent acute results and long-term, stroke-free outcomes [3]. - InspireMD's common stock is traded on Nasdaq under the ticker symbol NSPR [3]. Investor Relations - Interested parties can access the live earnings call via telephone or through a webcast available on the InspireMD investor relations website [2]. - A replay of the webinar will be available shortly after the call and will be archived on InspireMD's website [2]. - Investor contact information includes Craig Shore, Chief Financial Officer, and Webb Campbell from Gilmartin Group LLC [4].